Axsome Therapeutics (AXSM) EPS (Basic) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.09% |
| Dec 31, 2025 | 41.49% |
| Sep 30, 2025 | 3.09% |
| Jun 30, 2025 | 20.49% |
| Mar 31, 2025 | 20.78% |
| Dec 31, 2024 | -14.93% |
| Sep 30, 2024 | 19.76% |
| Jun 30, 2024 | -15.97% |
| Mar 31, 2024 | 32.39% |
| Dec 31, 2023 | -61.36% |
| Sep 30, 2023 | 14.29% |
| Jun 30, 2023 | -492.31% |
| Mar 31, 2023 | 81.82% |
| Dec 31, 2022 | -33.64% |
| Sep 30, 2022 | -0.94% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -17.78% |
| Dec 31, 2021 | 3.23% |
| Sep 30, 2021 | -8.14% |
| Jun 30, 2021 | -10.26% |
| Mar 31, 2021 | 1.27% |
| Dec 31, 2020 | -29.51% |
| Sep 30, 2020 | -24.49% |
| Jun 30, 2020 | 44.32% |
| Mar 31, 2020 | -23.94% |
| Dec 31, 2019 | -26.79% |
| Sep 30, 2019 | -36.59% |
| Jun 30, 2019 | -28.13% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | -3.23% |
| Sep 30, 2018 | 3.13% |
| Jun 30, 2018 | -68.42% |
| Mar 31, 2018 | 38.71% |
| Dec 31, 2017 | -14.81% |
| Sep 30, 2017 | 10.00% |
| Jun 30, 2017 | 26.83% |
| Mar 31, 2017 | -7.89% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | -5.56% |
| Jun 30, 2016 | -16.13% |
| Mar 31, 2016 | -34.78% |
| Dec 31, 2015 | 43.90% |
| Sep 30, 2015 | -115.79% |
| Jun 30, 2015 | 0.00% |